Targeting Funding Sources: A Strategic Mechanism of Research Regulation
Fleischman and colleagues (2011) recognize that essentially all national commissions and advisory bodies currently lack an effective mechanism of translating recommendations into policy, and historical successes of doing so have been sparse. In practice, then, a more targeted approach is necessary f...
Gespeichert in:
| Veröffentlicht in: | American journal of bioethics 2011-05, Vol.11 (5), p.17-18 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 18 |
|---|---|
| container_issue | 5 |
| container_start_page | 17 |
| container_title | American journal of bioethics |
| container_volume | 11 |
| creator | Schanker, Benjamin D. Ulvestad, Kchersti A. |
| description | Fleischman and colleagues (2011) recognize that essentially all national commissions and advisory bodies currently lack an effective mechanism of translating recommendations into policy, and historical successes of doing so have been sparse. In practice, then, a more targeted approach is necessary for national advisory bodies to effect policies and research agendas in meaningful ways. The potentially profound social implications of research require that risks and detrimental effects be assessed, and adequate steps be taken to avoid negative outcomes. Adapted from the source document. |
| doi_str_mv | 10.1080/15265161.2011.552164 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_908013595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>908013595</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-a870256e417dbae484726e2beb70154f33f3ee7fb9cb69c0a7d8683c7d8e85cb3</originalsourceid><addsrcrecordid>eNqFkE1Lw0AURQdRbK3-A5HsXKXO96RupBRbhYpg63qYTF7aSJKpMwnSf29CrUtd3bs47104CF0TPCY4wXdEUCmIJGOKCRkLQYnkJ2hIBJMxxkqc9p3KuGcG6CKED4wxx4SdowHtKE44HaLF2vgNNEW9ieZtnfW5cq23EO6jabRqvGlgU9joBezW1EWoIpdHbxDAeLvtyqYtTVO4-hKd5aYMcPWTI_Q-f1zPnuLl6-J5Nl3GlnHWxCZRmAoJnKgsNcATrqgEmkKqMBE8ZyxnACpPJzaVE4uNyhKZMNsFJMKmbIRuD3933n22EBpdFcFCWZoaXBv0pFNDmJiIf8lEcqW650lH8gNpvQvBQ653vqiM32uCde9aH13r3rU-uO7Obn4G2rSC7PfoKLcDHg5AUefOV-bL-TLTjdmXzufe1LYImv058Q2j4Yxq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>864778688</pqid></control><display><type>article</type><title>Targeting Funding Sources: A Strategic Mechanism of Research Regulation</title><source>MEDLINE</source><source>PAIS Index</source><source>HeinOnline Law Journal Library</source><source>Taylor & Francis</source><creator>Schanker, Benjamin D. ; Ulvestad, Kchersti A.</creator><creatorcontrib>Schanker, Benjamin D. ; Ulvestad, Kchersti A.</creatorcontrib><description>Fleischman and colleagues (2011) recognize that essentially all national commissions and advisory bodies currently lack an effective mechanism of translating recommendations into policy, and historical successes of doing so have been sparse. In practice, then, a more targeted approach is necessary for national advisory bodies to effect policies and research agendas in meaningful ways. The potentially profound social implications of research require that risks and detrimental effects be assessed, and adequate steps be taken to avoid negative outcomes. Adapted from the source document.</description><identifier>ISSN: 1526-5161</identifier><identifier>EISSN: 1536-0075</identifier><identifier>DOI: 10.1080/15265161.2011.552164</identifier><identifier>PMID: 21534142</identifier><language>eng</language><publisher>United States: Taylor & Francis Group</publisher><subject>Advisory Committees ; Bioethics ; Clinical Trials as Topic - economics ; Clinical Trials as Topic - ethics ; Financing, Government - ethics ; Health policy ; Human Experimentation - ethics ; Humans ; Medical research ; Public Policy - trends ; Regulation ; Research Support as Topic - ethics ; Risk ; Success ; United States</subject><ispartof>American journal of bioethics, 2011-05, Vol.11 (5), p.17-18</ispartof><rights>Copyright Taylor & Francis Group, LLC 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c343t-a870256e417dbae484726e2beb70154f33f3ee7fb9cb69c0a7d8683c7d8e85cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/15265161.2011.552164$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/15265161.2011.552164$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,776,780,27844,27903,27904,59624,60413</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21534142$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schanker, Benjamin D.</creatorcontrib><creatorcontrib>Ulvestad, Kchersti A.</creatorcontrib><title>Targeting Funding Sources: A Strategic Mechanism of Research Regulation</title><title>American journal of bioethics</title><addtitle>Am J Bioeth</addtitle><description>Fleischman and colleagues (2011) recognize that essentially all national commissions and advisory bodies currently lack an effective mechanism of translating recommendations into policy, and historical successes of doing so have been sparse. In practice, then, a more targeted approach is necessary for national advisory bodies to effect policies and research agendas in meaningful ways. The potentially profound social implications of research require that risks and detrimental effects be assessed, and adequate steps be taken to avoid negative outcomes. Adapted from the source document.</description><subject>Advisory Committees</subject><subject>Bioethics</subject><subject>Clinical Trials as Topic - economics</subject><subject>Clinical Trials as Topic - ethics</subject><subject>Financing, Government - ethics</subject><subject>Health policy</subject><subject>Human Experimentation - ethics</subject><subject>Humans</subject><subject>Medical research</subject><subject>Public Policy - trends</subject><subject>Regulation</subject><subject>Research Support as Topic - ethics</subject><subject>Risk</subject><subject>Success</subject><subject>United States</subject><issn>1526-5161</issn><issn>1536-0075</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7TQ</sourceid><recordid>eNqFkE1Lw0AURQdRbK3-A5HsXKXO96RupBRbhYpg63qYTF7aSJKpMwnSf29CrUtd3bs47104CF0TPCY4wXdEUCmIJGOKCRkLQYnkJ2hIBJMxxkqc9p3KuGcG6CKED4wxx4SdowHtKE44HaLF2vgNNEW9ieZtnfW5cq23EO6jabRqvGlgU9joBezW1EWoIpdHbxDAeLvtyqYtTVO4-hKd5aYMcPWTI_Q-f1zPnuLl6-J5Nl3GlnHWxCZRmAoJnKgsNcATrqgEmkKqMBE8ZyxnACpPJzaVE4uNyhKZMNsFJMKmbIRuD3933n22EBpdFcFCWZoaXBv0pFNDmJiIf8lEcqW650lH8gNpvQvBQ653vqiM32uCde9aH13r3rU-uO7Obn4G2rSC7PfoKLcDHg5AUefOV-bL-TLTjdmXzufe1LYImv058Q2j4Yxq</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>Schanker, Benjamin D.</creator><creator>Ulvestad, Kchersti A.</creator><general>Taylor & Francis Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TQ</scope><scope>DHY</scope><scope>DON</scope></search><sort><creationdate>201105</creationdate><title>Targeting Funding Sources: A Strategic Mechanism of Research Regulation</title><author>Schanker, Benjamin D. ; Ulvestad, Kchersti A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-a870256e417dbae484726e2beb70154f33f3ee7fb9cb69c0a7d8683c7d8e85cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Advisory Committees</topic><topic>Bioethics</topic><topic>Clinical Trials as Topic - economics</topic><topic>Clinical Trials as Topic - ethics</topic><topic>Financing, Government - ethics</topic><topic>Health policy</topic><topic>Human Experimentation - ethics</topic><topic>Humans</topic><topic>Medical research</topic><topic>Public Policy - trends</topic><topic>Regulation</topic><topic>Research Support as Topic - ethics</topic><topic>Risk</topic><topic>Success</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schanker, Benjamin D.</creatorcontrib><creatorcontrib>Ulvestad, Kchersti A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PAIS Index</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><jtitle>American journal of bioethics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schanker, Benjamin D.</au><au>Ulvestad, Kchersti A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Targeting Funding Sources: A Strategic Mechanism of Research Regulation</atitle><jtitle>American journal of bioethics</jtitle><addtitle>Am J Bioeth</addtitle><date>2011-05</date><risdate>2011</risdate><volume>11</volume><issue>5</issue><spage>17</spage><epage>18</epage><pages>17-18</pages><issn>1526-5161</issn><eissn>1536-0075</eissn><abstract>Fleischman and colleagues (2011) recognize that essentially all national commissions and advisory bodies currently lack an effective mechanism of translating recommendations into policy, and historical successes of doing so have been sparse. In practice, then, a more targeted approach is necessary for national advisory bodies to effect policies and research agendas in meaningful ways. The potentially profound social implications of research require that risks and detrimental effects be assessed, and adequate steps be taken to avoid negative outcomes. Adapted from the source document.</abstract><cop>United States</cop><pub>Taylor & Francis Group</pub><pmid>21534142</pmid><doi>10.1080/15265161.2011.552164</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1526-5161 |
| ispartof | American journal of bioethics, 2011-05, Vol.11 (5), p.17-18 |
| issn | 1526-5161 1536-0075 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_908013595 |
| source | MEDLINE; PAIS Index; HeinOnline Law Journal Library; Taylor & Francis |
| subjects | Advisory Committees Bioethics Clinical Trials as Topic - economics Clinical Trials as Topic - ethics Financing, Government - ethics Health policy Human Experimentation - ethics Humans Medical research Public Policy - trends Regulation Research Support as Topic - ethics Risk Success United States |
| title | Targeting Funding Sources: A Strategic Mechanism of Research Regulation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T06%3A31%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Targeting%20Funding%20Sources:%20A%20Strategic%20Mechanism%20of%20Research%20Regulation&rft.jtitle=American%20journal%20of%20bioethics&rft.au=Schanker,%20Benjamin%20D.&rft.date=2011-05&rft.volume=11&rft.issue=5&rft.spage=17&rft.epage=18&rft.pages=17-18&rft.issn=1526-5161&rft.eissn=1536-0075&rft_id=info:doi/10.1080/15265161.2011.552164&rft_dat=%3Cproquest_pubme%3E908013595%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=864778688&rft_id=info:pmid/21534142&rfr_iscdi=true |